The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo
- 30 June 2007
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 42 (6) , 1119-1128
- https://doi.org/10.1016/j.yjmcc.2007.03.900
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Localizing NADPH Oxidase–Derived ROSScience's STKE, 2006
- Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytesPublished by Oxford University Press (OUP) ,2006
- CARDIAC HYPERTROPHY, SUBSTRATE UTILIZATION AND METABOLIC REMODELLING: CAUSE OR EFFECT?Clinical and Experimental Pharmacology and Physiology, 2006
- Pivotal Role of gp91
phox
-Containing NADH Oxidase in Lipopolysaccharide-Induced Tumor Necrosis Factor-α Expression and Myocardial DepressionCirculation, 2005
- The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the ratJournal Of Hypertension, 2003
- Glycogen Synthase Kinase-3βCirculation Research, 2002
- Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heartJournal of Clinical Investigation, 1999
- Two-Week Administration of Tempol Attenuates Both Hypertension and Renal Excretion of 8-Iso Prostaglandin F 2αHypertension, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).Journal of Clinical Investigation, 1995